Clinical Trials Directory

Trials / Completed

CompletedNCT07068451

Greater Occipital Nerve Block Alone Versus Dual Nerve Block in Cervicogenic Headache and Occipital Neuralgia

A Prospective Randomized Study Comparing Greater Occipital Nerve Block Alone Versus Dual Nerve Blockade in the Management of Cervicogenic Headache and Occipital Neuralgia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Tishreen University Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study looked at two types of nerve block injections used to treat people with cervicogenic headache (CEH) and occipital neuralgia (ON)-two painful conditions that often cause pain at the back of the head and neck. The injections target nerves in the upper neck that may be causing the pain. The researchers compared: One nerve injection (greater occipital nerve block, or GONB), versus Two nerve injections (GONB plus lesser occipital nerve block, or LONB).

Conditions

Interventions

TypeNameDescription
PROCEDUREGreater Occipital Nerve Block (GONB)A landmark-guided injection of 1 mL of 2% lidocaine administered at the anatomical location of the greater occipital nerve (GON) to treat cervicogenic headache and occipital neuralgia. Performed without corticosteroids or imaging guidance.
PROCEDURECombined Greater and Lesser Occipital Nerve Block (GONB + LONB)Two landmark-guided injections of 1 mL of 2% lidocaine each at the anatomical locations of the greater and lesser occipital nerves. Performed without corticosteroids or imaging, targeting broader nerve involvement in cervicogenic headache and occipital neuralgia.

Timeline

Start date
2020-01-01
Primary completion
2023-04-01
Completion
2023-04-01
First posted
2025-07-16
Last updated
2025-07-16

Locations

1 site across 1 country: Syria

Source: ClinicalTrials.gov record NCT07068451. Inclusion in this directory is not an endorsement.